Menu
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€1.94

€1.94

3.970%
0.075
3.970%
-
 
17.08.26 / Tradegate WKN: A40AEG / Name: Pentixapharm Holding / Stock / ? /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Pentixapharm Holding AG Stock

A very strong showing by Pentixapharm Holding AG today, with an increase of €0.075 (3.970%) compared to yesterday's price.

Pros and Cons of Pentixapharm Holding AG in the next few years

Pros
?
M***** P*******
?
B****
?
G***** c******* t* c**********
Cons
?
S********** s********
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'

News

EQS-News: Pentixapharm Reports Second Quarter and First Half 2026 Results and Advances Phase 3 Panda Program
EQS-News: Pentixapharm Reports Second Quarter and First Half 2026 Results and Advances Phase 3 Panda Program
EQS-News: Pentixapharm Reports Second Quarter and First Half 2026 Results and Advances Phase 3 Panda Program
EQS-News: Pentixapharm Completes Capital Increase – New Shares Placed in Full
EQS-News: Pentixapharm Completes Capital Increase – New Shares Placed in Full
EQS-News: Pentixapharm Completes Capital Increase – New Shares Placed in Full
EQS-Adhoc: Pentixapharm Holding AG completes rights offering and private placement with significant oversubscription generating gross proceeds of approx. EUR 20.4 Million already today
EQS-Adhoc: Pentixapharm Holding AG completes rights offering and private placement with significant oversubscription generating gross proceeds of approx. EUR 20.4 Million already today
EQS-Adhoc: Pentixapharm Holding AG completes rights offering and private placement with significant oversubscription generating gross proceeds of approx. EUR 20.4 Million already today